These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 9602424

  • 1. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD, Dostal D, Baker K.
    J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
    [Abstract] [Full Text] [Related]

  • 2. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
    McWhinney CD, Hunt RA, Conrad KM, Dostal DE, Baker KM.
    J Mol Cell Cardiol; 1997 Sep; 29(9):2513-24. PubMed ID: 9299374
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB.
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
    [Abstract] [Full Text] [Related]

  • 4. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor.
    Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE.
    Nature; 1995 May 18; 375(6528):247-50. PubMed ID: 7746328
    [Abstract] [Full Text] [Related]

  • 5. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
    Omura T, Yoshiyama M, Ishikura F, Kobayashi H, Takeuchi K, Beppu S, Yoshikawa J.
    J Mol Cell Cardiol; 2001 Feb 18; 33(2):307-16. PubMed ID: 11162135
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L, Flores-Morales A, Lahuna O, Sliva D, Norstedt G, Haldosén LA, Mode A, Gustafsson JA.
    Endocrinology; 1998 Apr 18; 139(4):1815-24. PubMed ID: 9528967
    [Abstract] [Full Text] [Related]

  • 11. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
    Gallmeier E, Schäfer C, Moubarak P, Tietz A, Plössl I, Huss R, Göke B, Wagner AC.
    J Cell Physiol; 2005 Apr 18; 203(1):209-16. PubMed ID: 15493010
    [Abstract] [Full Text] [Related]

  • 12. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
    Li PG, Xu JW, Ikeda K, Kobayakawa A, Kayano Y, Mitani T, Ikami T, Yamori Y.
    Hypertens Res; 2005 Apr 18; 28(4):369-77. PubMed ID: 16138568
    [Abstract] [Full Text] [Related]

  • 13. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J.
    Oncogene; 2001 Oct 04; 20(45):6643-50. PubMed ID: 11641791
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.
    Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB.
    Kidney Int; 2002 May 04; 61(5):1605-16. PubMed ID: 11967010
    [Abstract] [Full Text] [Related]

  • 15. Janus kinase 2 (Jak2) must be catalytically active to associate with the AT1 receptor in response to angiotensin II.
    Ali MS, Sayeski PP, Safavi A, Lyles M, Bernstein KE.
    Biochem Biophys Res Commun; 1998 Aug 28; 249(3):672-7. PubMed ID: 9731195
    [Abstract] [Full Text] [Related]

  • 16. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor.
    Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB, Bernstein KE.
    J Biol Chem; 1997 Sep 12; 272(37):23382-8. PubMed ID: 9287353
    [Abstract] [Full Text] [Related]

  • 17. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
    Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC.
    Am J Physiol; 1998 Nov 12; 275(5):C1216-23. PubMed ID: 9814969
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.
    Mol Endocrinol; 1998 Apr 12; 12(4):556-67. PubMed ID: 9544991
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E, Negrín-Martínez C, Novoa-Mogollón J, Fernández-Perez L, Flores-Morales A.
    Exp Cell Res; 2004 Mar 10; 294(1):269-80. PubMed ID: 14980520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.